# Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply Canonical URL: https://biopharmsignal.com/news/XRAY/dentsply-sirona-expands-u-s-distribution-footprint-through-enhanced-agreement-wi-e8d1b3b1 Ticker: XRAY Company: DENTSPLY SIRONA Inc. Source: DENTSPLY SIRONA Inc. Published: 2026-05-04 21:00 EST ## Summary Dentsply Sirona (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental... ## Article Body Dentsply Sirona (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced an enhanced distribution agreement with Atlanta Dental Supply, under which Atlanta Dental will begin offering Dentsply Sirona’s connected technology solutions portfolio in the United States as of August 1. The expanded agreement strengthens Dentsply Sirona’s U.S. go-to-market strategy by extending its digital dentistry offerings through a well-established, independent regional distributor with deep customer relationships across the Southeast. Atlanta Dental Supply, 100% employee-owned, founded in 1868, is a privately held dental distributor serving practices with dental supplies, equipment, technology, and dedicated service support. Under the enhanced agreement, Atlanta Dental Supply will begin offering key digital dentistry technologies from Dentsply Sirona, including the CEREC system , intraoral scanning , and digital imaging solutions . “Expanding access to our digital dentistry technologies through trusted distribution partners is a core element of our commercial strategy,” said Mark Bezjak, Group Vice President Americas, Dentsply Sirona. “Atlanta Dental Supply’s regional scale, service infrastructure, and long-standing relationships with independent practices make them a strong partner for reaching customers where and how they prefer to buy.” The agreement supports Dentsply Sirona’s focus on disciplined distribution expansion, customer centricity, and localized commercial execution through established partners. Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. About Dentsply Sirona Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products. Contact Information: Dentsply Sirona Press Contact: Marion Par-Weixlberger Vice President, Corporate Communications, Public Relations & Brand Publicrelations@dentsplysirona.com | www.dentsplysirona.com Dentsply Sirona Investors: Wade Moody Senior Manager, Investor Relations Investorrelations@dentsplysirona.com ## Recent Company News - 2026-07-28 12:30 EST — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2) — Source: DENTSPLY SIRONA Inc. - 2026-07-21 20:15 EST — [Dentsply Sirona to Host Second Quarter Conference Call on August 6th](https://biopharmsignal.com/news/XRAY/dentsply-sirona-to-host-second-quarter-conference-call-on-august-6th-21fd2675) — Source: DENTSPLY SIRONA Inc. - 2026-07-01 21:00 EST — [PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry](https://biopharmsignal.com/news/XRAY/pds-health-surpasses-five-million-cerec-chairside-restorations-with-dentsply-sir-7db929d4) — Source: DENTSPLY SIRONA Inc. - 2026-06-11 12:30 EST — [Dentsply Sirona Appoints John Fortson as Chief Financial Officer](https://biopharmsignal.com/news/XRAY/dentsply-sirona-appoints-john-fortson-as-chief-financial-officer-fc7266be) — Source: DENTSPLY SIRONA Inc. - 2026-05-26 20:30 EST — [Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets](https://biopharmsignal.com/news/XRAY/dentsply-sirona-continues-to-expand-u-s-distribution-network-to-strengthen-acces-23141708) — Source: DENTSPLY SIRONA Inc. ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)